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Abstract
In analytic chemistry a detection limit (DL) is the lowest measurable amount of an analyte that can be distinguished from a
blank; many biomedical measurement technologies exhibit this property. From a statistical perspective, these data present
inferential challenges because instead of precise measures, one only has information that the value is somewhere between 0
and the DL (below detection limit, BDL). Substitution of BDL values, with 0 or the DL can lead to biased parameter estimates
and a loss of statistical power. Statistical methods that make adjustments when dealing with these types of data, often called
left-censored data, are available in many commercial statistical packages. Despite this availability, the use of these methods is
still not widespread in biomedical literature. We have reviewed the statistical approaches of dealing with BDL values, and used
simulations to examine the performance of the commonly used substitution methods and the most widely available statistical
methods. We have illustrated these methods using a study undertaken at the Vanderbilt-Ingram Cancer Center, to examine the
serum bile acid levels in patients with colorectal cancer and adenoma. We have found that the modern methods for BDL values
identify disease-related differences that are often missed, with statistically naive approaches.
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Methods that account for left-censoring have been utilized by statisticians for many years, particularly for measurement of
environmental  contaminates  (e.g.,  arsenic)  in  water.  [1],[2]  In  biomedicine,  vaccine  studies  and  HIV  [3]  have  driven
methodological development. Despite the fact that many of the methods are well-established, new applications and extensions
remain a statistician's research topic. [4] Recent research in biomarker discovery studies has provided a new impetus for
development of methods. [5],[6] This article, and the illustrative example, focus on situations where outcomes are measured
with BDL values. Statistical treatment is similar whether the outcome or the exposure / predictor is measured with DL, [7]
however, fewer software options are available when the exposure is measured with values below the DLs.
Reviews of  statistical  methods for  estimation and analysis  of  data with DLs are abundant,  particularly  in  the literature of
environmental  sciences.  [8],[9],[10]  Many  of  the  reviews  are  concerned  with  estimation  and  provide  estimates  of  bias
(difference  between  the  estimated  mean  under  a  given  method  and  the  true  mean)  and  coverage  probabilities  of  95%
confidence intervals. We focus our discussion on a subset of methods that closely link estimation and hypothesis tests. They
include substitution, nonparametric, and maximum likelihood methods.
Naive methods for handling data of this nature include deletion or simple substitution with the DL, DL/2, or even zero. After
substitution, the 'usual' statistical methods are used to obtain parameter estimates and test hypotheses, for example, linear
regression and two-sample t-test. Although simple to implement, it has been demonstrated that parameter estimates resulting
from these methods are biased; [8],[9],[10] furthermore, there is little mathematical justification for their use, as pointed out by
Slymen. [2] Substitution of a BDL value with zero, biases the mean tolower than the true mean and substitution with the DL
biases the mean to higher than the true mean. Substitution with half the DL has been shown to have reasonable properties
under  specific  conditions,  but  in  general,  it  has been shown to  be biased;  [8],[9],[10]  furthermore,  Slymen [2]  accurately
elaborates that this substitution assumes that the distribution of the BDL is uniform over the range between zero and the DL,
and not a standard assumption. A very informative and thorough review can be found in Helsel. [11] It is noteworthy that the
author, Helsel, wrote a similar review 15 years ago, [12] and has remarked that within the environmental sciences, substitution
methods are still the most commonly employed. Helsel further points out in the earlier work that as methods are easily available
and given the bias that is induced with estimation by methods of substitution, their continued use is simply 'not defensible'. [12]
Nonparametric methods
Regression on the order statistics (ROS) methods are based on a simple linear regression model using ordered detected
values and distributional (normal) quantiles to estimate the concentration of the censored (BDL) values; [13] they are also
called 'probability plot methods'. [12] This is actually a semi-parametric method, as the quantiles are obtained by assuming an
underlying parametric distribution for the uncensored values. Often the data are transformed before the order statistics are
obtained. For example,  the NADA package in R defaults to the log transformation,  but  other transformations could be of
interest. Once the censored values are estimated, then the usual methods of parameter estimation and hypothesis testing are
employed. Although this method has been shown to be fairly robust to the proportion of BDL data, and in the presence of
moderate skewness,  the bias becomes problematic  in  the presense of  highly  skewed data.  [1]  Alternative nonparametric
methods rely on Kaplan-Meier estimates and log-rank or Peto-Prentice test statistics.[14] The estimates are obtained using the
usual empirical cumulative distribution function for censored data, [15] and the test statistics are the same, as is typically used
with right- or interval-censored data. As with all nonparametric procedures, these estimates are relatively unbiased, although
the test statistics are not as powerful as their parametric counterparts when the underlying distribution is known or can be
approximated.
Maximum likelihood methods
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Maximum likelihood methods are based on approximating the distribution of the observed data with a parametric distribution.
Parameters  are  estimated  to  create  a  distribution  under  which  the  observations  are  'most  likely'.  Hypotheses  regarding
plausible values of the parameters may be tested with regard to the observed data. The most common statistical model for
biologic data posits a log-normal (or normal) probability distribution. Often the logrithmic transformation is preferred to help
stabilize  the  variance and reduce large discrepancies in  magnitude between smallest  and largest  values.  The censoring
mechanism can be easily incorporated into these parametric models, and most commercial statistical packages have some
facility to estimate and test parameters from these models. [11],[16] Additional methods that fall under this broad category of
maximum likelihood include mixture models, and some methods of multiple imputation.
Mixture models are useful when the proportion of the values of BDL are higher than would be expected under other parametric
models, or more importantly,  when there are 'true' zero's in addition to the BDL values due to limitations in the assay or
measurement technique. One of the most common applications for mixture distributions is measurement of serum antibody
levels in infectious disease. In this situation, one may never have been exposed to the antigen or have lost acquired immunity,
and  having no  (or  zero)  antibodies  is  a  possibility.  The  basic  approach is  to  model  a  mixture  of  two components:  One
component estimates the probability of having no measurable amount, and the second describes the distribution for values
above the DL. The first component is generally modeled by a binomial distribution (sometimes referred to as the Bernoulli
component) and the second component generally uses the log-normal or normal distribution. [3],[4] Estimation is performed
independently for each component and hypothesis testing is done by combining the likelihoods for both components. One of
the best introductions to the approach of combining likelihoods can be found in Lachenbruch; [17] although, censoring is not
included in this description. Finally, another method that is based on likelihood is multiple imputation. Multiple imputation (MI)
methods have become prevalent for use with data having missing values. [18] Imputation is used to 'fill in' the missing (or BDL)
values, based on patterns from the non-missing data. Although most commonly used commercial statistical packages have
imputation algorithms, it has been shown that these might be inappropriate when 'missingness' is due to values BDL. [16]
Choosing the appropriate imputation model is the key in the utility of these methods, and if the wrong imputation model is used,
the results are not much better than the other approaches described. Also, higher levels of censoring will result in greater bias
in parameter estimates.
To demonstrate the properties of competing statistical methods, we simulated data from the lognormal distribution and from the
exponential distribution. For these simulations we were interested in estimating mean parameters in two groups and testing the
differences between the parameters. We examined the 'bias' (difference between estimated parameter and true value from the
underlying simulation) and power of the test to detect a difference. The underlying parameters for the simulation were chosen
to provide approximately 80% power to samples sizes that were relevant to our bile acid example.
As the lognormal distribution is the most commonly used distribution with biomedical data, the exponential distribution provides
a useful check for comparison of methods with model misspecification. The censored fraction ranges from 40 to 60%, a fraction
commonly observed with bile acid measurements. Simulation parameters for the lognormal are μ1 = 0.50 and μ2 = 1.0 for the
location  parameter,  and  s1 =  s2  =  1.0  for  the  scale  parameter.  Subscripts  1  and 2  denote  the  sample  group  identifier.
Simulation parameters for the exponential distribution are means of 3 and 5 for groups 1 and 2, respectively, and a common
scale parameter of 1.0. All simulations have been repeated 1000 times. We have evaluated bias and power under three types
of substitution, zero, half-DL, and the DL, as well as estimated them under KM (using Peto-Prentice test statistics), ROS, and
censored regression assuming lognormal distribution (labeled ML). [Table 1] shows the estimated parameters, standard errors,
bias (difference between true and estimated test statistics) and power under the three levels of censoring for substitutions from
the lognormal distribution. Simulations from the exponential distribution can be found in [Table 2].{Table 1}{Table 2}
These simulations are similar  to  those in  previous studies.  [1],[8],[9],[10]  When data come from a lognormal  distribution,
estimation (bias) and power (performance of inferential  procedure) are both maximized. For simulations from a lognormal
distribution  the  substitution  methods  have  demonstrated  decent  power  to  detect  pairwise  differences.  However,  there  is
significant bias even at the lower levels of censoring. Both ROS and ML methods have performed better than the substitution
methods in terms of power and bias, although ML methods are less biased, regardless of the amount of censoring. When
underlying simulated data are generated from the exponential distribution, the results are mixed. Surprisingly, substitution with
half-DL has performed as well as ML and ROS methods, with regard to bias and with little loss of power. We caution the reader,
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that  the  positive  results  for  this  method  are  likely  due  to  characteristics  of  our  underlying  model  (e.g.,  the  exponential
distribution is highly right-skewed, which limits the range between zero and the DL limit). We do not feel that this behavior will
be consistent for arbitraty deviations from normality (or lognormality). Shumway [1] also shows that ML and ROS methods are
similar, except in the case of highly-skewed distributions, where ML has outperformed the ROS methods. This is similar to what
we have demonstrated with simulations for the exponential distribution. We have observed reduced bias in the ML method
compared to ROS. Additionally, Shumway [1] has observed that the ML methods are biased in small samples, with increased
censoring. This is also consistent with our results. With 60% censoring and relatively small sample sizes, power under the ROS
methodology is greater, and the difference in the bias is quite small.
These simulations demonstrate that ML methods exhibit better performance in terms of reduced bias and increased power
when the underlying distribution is well-approximated by a parametric model. When it is not clear that data can be modeled
using  a  parametric  distribution,  either  because  of  sample  size  or  distributional  assumptions,  then  ROS (or  perhaps  KM
depending  on  the  sample)  is  a  sensible  alternative.  Although not  ideal,  the  parametric  ML method  using  the  lognormal
distribution performs well, with respect to power, even when the underlying distribution is not lognormal; although the ROS
method is clearly more powerful.  Even as methods for estimation using ROS are implemented intostandard software, test
statistics based on this estimation are not as well developed. A limitation to the KM method is that models are limited to one
categorical covariate. Overall, even with relatively small sample sizes and 60% censoring, ML methods perform adequately,
even with a misspecified distribution. Our suggestion would be to perform a sensitivity analysis when distributional assumptions
are questionable, to assess the performance of the estimation procedures; when there is a large difference between methods a
trade-off will need to be made between power and bias. In all cases, we recommend ceasing the use of substitution methods
for data with DL.
Background
Nutritional factors such as a diet high in fat have been associated with colon cancer development. [19] A number of studies
have suggested that elevated levels of  secondary bile acids (BAs) may be in part  responsible for  this association.[20]  In
response to fat intake, BAs are secreted to aid in the absorption of cholesterol and fat-soluble vitamins. [21] BAs exist in
several forms. The primary BAs such as cholic acid (CA) and chenodeoxycholic acid (CDCA) are derived from cholesterol in
the liver and are secreted in the bile, mainly as glycine or taurine conjugates. In the colon, secondary bile acids, deoxycholic
acid (DCA) and lithocholic acid (LCA), are formed from conjugated forms of CA and CDCA, respectively, through deconjugation
and dehydroxylation, by the anaerobic bacterial flora. Subsequently, the tertiary bile acids, ursodeoxycholic acid (UDCA) and
sulpho-LCA (SLCA) are formed through epimerization of CDCA or sulfation of LCA. BAs are absorbed from the intestines into
the  portal  blood  system  via  'enterohepatic  circulation,'  resulting  in  circulating  concentrations  of  0.01  -  0.02  mmol/l,
predominantly bound to albumin. In the circulation, CA and CDCA each comprise of about 30 - 40%, DCA about 20 - 30%, and
LCA < 5% of the total amount of detectable BAs. DCA and LCA, the main fecal bile acids, are suspected to be the forms of bile
acids that are implicated in colorectal carcinogenesis.
Several  epidemiological  studies  indicate  an  association  between BAs and colorectal  cancer.  Elevated fecal  levels  of  the
secondary BAs [22] with higher fecal LCA / DCA ratios [23] are seen in patients with colorectal cancer, as compared to healthy
volunteers.  Additionally,  male  patients  with  colon adenomas have higher  serum levels  of  DCA than control  patients  with
negative colonoscopies.  [24]  These studies,  however,  have measured levels  of  only  a few select  BAs. Using a sensitive
HPLC-mass spectrometry assay, we simultaneously determined the serum levels of all major BAs in healthy volunteers and
patients with  colorectal  ademonas and cancers of  all  clinical  stages.  A recent  review article  lays out  a  strong Darwinian
argument for the accumulation of damage from high levels of bile acids as a strong risk factor for GI cancer. [25] Given this
evidence, we wish to closely examine the difference in serum bile acid concentrations in three groups of patients, those with
colorectal cancer, adenomatous polyps, and normal colorectal mucosa.
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Patient samples
Serum samples from patients with normal colonoscopies, adenomatous polyps, and colorectal cancers were collected from
2001 - 2007 at Vanderbilt University Medical Center. In addition, tumor specimens of a majority of colon cancer patients were
also collected at the time of operation. In total, serum from 177 patients was collected. This included, 50 normal patients, 31
with adenoma, and 96 with colorectal cancer. This was a cross-sectional sample, there was no matching or sampling procedure
performed.
Sample processing
Using a sensitive HPLC-mass spectrometry assay, we analyzed a portion of our collected samples for their serum levels of
major BAs in their unconjugated, as well as glycine- and taurine-conjugated forms (15 individual BAs). For the purpose of
illustration of the methods described here, we will focus only on the unconjugated BAs in this manuscript. The serum samples
(100 μL) were processed by mixing them with an equal volume of D4-CDCA (1 μM) as an internal standard and subsequently
with 1 mL of ice-cold acetonitrile (CH3 CN). The supernatant fraction was separated by centrifugation at 13,000 g for 20
minutes and evaporated to dryness using Speed-Vac. The samples were reconstituted using 150 μl  of  the mobile phase.
Calibration samples containing known concentrations of five major bile acids were processed simultaneously with the patient
serum samples.
Liquid chromatographic conditions and mass spectrometric detection
Analyses of serum BAs were carried out using a Surveyor HPLC system (Thermo-Electron) and mass spectrometric detection
was performed using an LTQ mass spectrometer (Thermo-Electron) equipped with a standard API-1 electrospray source. To
maintain maximum sensitivity, the selected ion monitoring (SIM) parameters for the detection of each bile acid were optimized.
An Acquity BEH C18 column (1.0 mm x 10 mm, 1.7 μm, source) was used for all chromatographic separations. The column
and autosampler tray temperatures were maintained at 60°C and 10°C, respectively. The mobile phases were made up of 10
mMtributyl ammonium acetate in (A) H2 O / CH3 CN(5:95) and in (B) H2O/CH3CN (95:5). Gradient conditions were as follows:
0 - 0.5 minutes, B = 32.5%; 0.5V - 5 minutes, B = 32.5 - 57.5%; 5 - 5.25 minutes, B = 57.5 - 100%; 5.25 - 8 minutes, B = 100%;
8 - 8.25 minutes, B = 100 - 32.5%; 8.25 - 13 minutes, B = 32.5%. The flow rate was maintained at 200 μL / minute. The total
chromatographic run time was 13 minutes. The sample injection volume was 5 μL. The autosampler injection valve and syringe
needle were flushed and rinsed with H2 O / CH3 CN (1 : 1) between each injection. The mass spectrometer was operated in
the negative ion mode. Quantitation was based on selected reaction monitoring for the corresponding m / z ratios of each bile
acid.  Data  acquisition  and quantitative  spectral  analysis  were  conducted  using  Thermo-FinniganXcaliber  version  2.0  and
Thermo-FinniganLCQuan version 2.5, respectively. The calibration curves were constructed by plotting the peak area ratios of
each bile acid over the internal standard (D4-CDCA) against the analyte concentrations for a series of BA standards.
Statistical analysis
Our primary interest is to test whether there are statistically significant differences in the mean BA concentrations between
normal, adenoma, and cancer patients. We are interested both in pair-wise differences as well  as a trend from normal to
cancer. We used ML (censored lognormal or mixture distribution) methods to estimate the means and their 95% confidence
intervals, unless there was reason to believe that the data were markedly not lognormally distributed. We used the F-statistic to
test the overall and trend when ML methods based on the lognormal distribution were used; the Peto-Prentice test was used for
any BA that was estimated by KM methods and a likelihood ratio c2 test statistic was applied for mixture models. We performed
two types of hypothesis tests, pair-wise tests to assess differences between any two patient types (e.g., normal versus cancer)
and a test for linear trend going from normal to cancer. To examine the distribution of the bile acids (as well as demonstrate the
proportion of values below the DL) we examined histograms for each bile acid by patient group. Lognormal probability plots,
along with 95% confidence intervals were used to judge the fit of the lognormal distribution to each BA. The difference between
the observed proportion of BDL and the expected probability of BDL under a censored lognormal distribution was calculated for
each bile acid. A difference greater than 0.1 indicated that a Bernoulli  /  lognormal mixture distribution should be used to
estimate test group-wise differences. [3] We also examined the correlation between each unconjugated BA and the other BAs
using a Kendall's tau correlation coefficient, per Akritas. [26] We examined BA concentration differences in adenomas less than
3 cm versus those greater than 3 cm, as a proxy for advanced stage, and between stages in cancer samples. Analyses were
done in R version 2.8.0 ( http://www.r-project.org ) and SAS version 9.2 (SAS Institute, Carey NC).
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Demographic and sample information can be found in [Table 3]. The pathological stage and adenoma subtype were based on a
medial record search and was not obtained as part of the serum collection. Large adenomas were defined as any adenoma
greater than 3 cm. Within the adenoma group there was one FAP patient, one patient with polypoid hyperplasia, and one
patient missing a pathological record.{Table 3}
[Figure 1] shows the histograms for each of the bile acids for each patient type (Normal, Adenoma, Cancer); the light gray bar
between 0 and 1 denotes the proportion of samples that fall below the DL, the actual percentages are listed in [Table 4].{Table
4}{Figure 1}
The probability plots indicated that the distributions for LCA and UDCA concentrations depart from the lognormal distribution
(not shown), as demonstrated by the lack of fit of the points to the 45° line. Furthermore, for UDCA, the differences in the
observed and expected probability was 0.144, which indicated a larger-than-expected proportion of censoring, necessitating
the need for  mixture distribution  modeling.  We compared the estimates (and test  statistics)  from the ROS, KM, and ML
methods for LCA, and the estimates were identical across the methods. Therefore, we decided to use the ML methods, despite
the indication of a slight departure from the lognormal distribution.
We investigated by using mixture models to estimate the test differences in the UDCA concentrations. We used the Akaike
Information Criterion (AIC) as a metric to choose between models (Akaike, 1974). The AIC combines a model goodness-of-fit
measure (the log likelihood) with a penalty for the number of parameters. Models can be ranked according to AIC, and the
smallest  AIC is  the 'best'  fitting model.  From these comparisons there is no evidence to suggest  that  adding a Bernoulli
component is necessary. Therefore, we have used ML estimation and hypothesis tests for this BA.
[Table 5] shows the overall means for each BA, as estimated by modeling using the censored lognormal distrubution along with
95% confidence intervals  for  each patient  group.  There  were  higher  mean DCA levels  in  adenoma and cancer  patients
compared to normal subjects, however, this difference was not statistically significant. It is likely that this was due to a high
variability in this BA (demonstrated by very large confidence limits). LCA and CDCA showed statistically significant differences
between the groups, with pairwise differences between normal versus cancer for CDCA (P-value = 0.0100) and between
normal and both cancer and adenoma (P values = 0.0326 and 0.0059, respectively) for LCA. All p-values shown in [Table 4]
are based on test statistics from ML method (assuming a lognormal censored distribution) as well as 'straw man' P-values
when substitution by zero was used.  Note that  if  the values below the DL had been replaced by zeros,  the statistically
significant  difference  in  LCA would  not  have  been  detected.  CDCA,  LCA,  and  UDCA,  all  showed statistically  significant
increasing trends in the mean concentrations going from normal to adenoma to cancer. Again, DCA also exhibited this trend,
but with the high degree of variability present, it was not statistically significant.{Table 5}
We also tested the mean differences in BA concentrations for each of the four cancer stages and between them. However, the
sample sizes for these subgroups were small (28, 18, 23, and 27 for stages 1 - 4, respectively) and we were not able to detect
any statistically significant differences. Graphical representation of these means and 95% confidence intervals can be found in
[Figure  2].  Mean  LCA,  CDCA,  and  UDCA  concentrations  for  stage  4  are  higher  than  for  stages  1  -  3.  Although  CA
concentrations are lower in stage 1 than all other stages, DCA concentrations show a general trend for increasing levels for
stages 2 - 4, while stage 1 has mean concentration levels similar to stage 4. Similar to the patient group analyses, this BA has
exhibited a large degree of variability, resulting in wide confidence limits.{Figure 2}
The sample size was not large enough to examine adenoma subtypes, however, we used the adenoma size as a proxy for
advanced adenoma (large adenomas were those larger than 3 cm). There were no statistically significant differences between
large and not large adenomas, the mean concentrations and 95% confidence intervals for each bile acid can be found in
[Figure 2].  The mean levels in DCA were lower for  large adenomas, 46.92 nM (95% confidence interval:  15.51, 142.00),
compared to 137.81 nM (95% confidence interval: 52.97, 358.54), but there was a lot of variability in concentrations, in both
groups. The analysis did not include two patients with three and four polyps, the FAP patient, or the patient with polypoid
hyperplasia, and there was one patient with missing pathology data.
Finally, we wanted to test the correlation between all five unconjugated BAs. We used Kendell's tau, which is a measure of
concordance between two measures. Kendell's tau is based on ranks, and it adjusts for ties when many observations have the
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same value. [Table 6] shows the correlation matrix for the BAs. The highest correlation, and only correlation above 0.5, is
between LCA and DCA, the two most common BAs associated with colon cancer.{Table 6}
We have described the most commonly used methods for summarizing and analyzing data with BDL values. We used a
simulation study to demonstrate the properties of these methods, particularly compared to the frequently used substitution
methods.  For  the most  part,  when the underlying distribution could be described using a parametric  distribution (normal,
lognormal, Weibull, etc.) the ML methods worked best for censored data; meaning they had the lowest bias and highest power.
When there was a large amount of skewness, the ML methods were still a viable alternative, although in special cases their
advantage over nonparametric, or even substitution methods, was unclear.
As ML methods are easy to implement in most commercial statistical software, there is little reason for the continued use of
naive substitution methods for data with observed DLs. There are cases when more sophisticated models must be used; and
determination of when their use is required is both conceptual (depends on what is being measured and whether true zeros are
expected) and statistical (whether there appear to be a greater than expected number of BDL values). For most practical
problems, especially with a large percentage of BDL values, we do not advocate the use of MI methods with these types of
data.
As an example, we examined the serum levels of five common unconjugated primary and secondary BAs from a population of
patients with cancer and adenomous polyp disease, and compared them with serum from patients with normal colonoscopy.
We used a combination of graphical methods (histograms and quantile-quantile (QQ) plots) for testing the probability of higher
than expected proportion of BLD values, to choose between ML, mixture distributions, or nonparametric methods of estimation
and testing for group differences. We found statistically significant differences in CDCA concentration levels between normal
and cancer groups, and between normal and both adenoma and cancer in LCA. We found a statistically significant increasing
trend in concentrations (from normal to adenoma to cancer) for CDCA, LCA, and UDCA BAs. Of note, and pertinent to the
actual  focus  of  this  manuscript,  differences  in  LCA and  the  significant  trend  in  CDCA would  not  have  been  detected  if
substitution by zero was utilized as the analytic method. We expected to see differences in the DCA concentration between the
normal and cancer, and possibly between the normal and adenoma groups, but because of the high degree of variability in
these measures we were unable to detect a statistically significant difference.
We did not find a strong pairwise correlation between these five BAs. A possible explanation is that the multivariate relationship
between these BAs is 'compositional'  in nature; compositional  data arise when the total  amount is fixed and variability  is
observed in the relative amounts of the different forms. Therefore, as one BA concentration increases the others would need to
decrease, and large positive correlations are tempered by the fixed total.
This particular example, although pertinent to the discussion of prevention of colon cancer, was used primarily for illustrative
purposes. Our future work will be to investigate all 15 BAs, the five unconjugated forms along with their glycine- and taurine-
conjugated forms. Primary hypotheses include the examination of how these conjugated forms differ between patient groups,
as  well  as  their  relationship  with  the  unconjugated  forms.  These  investigations  will  necessitate  the  development  of  new
statistical methods, or an extension of the existing methods. Furthermore, we are interested in investigating the utility of using
serum BA concentration as a predictor, or classifier, for cancer. Characterizing data when the predictor has DL remains an
open statistical research topic. Addtionally, we are currently working on evaluating the predictive ability of BA concentrations for
adenomous  polyp  disease  and  cancer.  All  of  these  future  considerations  will  necessitate  the  implementation  of  current
statistical  methodologies,  as  well  as  extentions  and novel  strategies.  Knowledge of  appropriate  statistical  methods  is  an
important aspect of all cancer research.
This study was supported in part by funding from the National Cancer Institute (NCI): P50 CA95060 [Arizona Cancer Center
SPORE in GI Cancer (LaFleur)] and P50 CA09513 [Vanderbilt GI SPORE Program (Merchant, LaFleur)].
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